We measured three biomarkers from patient sera; CA125, HE4 and REG4 and found high concentrations of REG4 in preoperative samples of mucinous ovarian cancer patients, whereas CA125 and HE4 failed to convincingly detect malignancy in these samples. This evidence concerns the gene MUC16 and mucinous ovarian cancer.